New drug eases the dryness and pain of Sjögren's disease

Sjögren's is an autoimmune condition where the body's defenses mistakenly attack its own moisture glands, leaving people with parched eyes and mouth, joint pain, and exhaustion. In a late-stage trial, Amgen's dazodalibep calmed the immune attack and relieved symptoms — a first for a disease with no approved targeted treatment.